KalVista Pharmaceuticals
KALV
KALV
57 hedge funds and large institutions have $261M invested in KalVista Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 8 closing their positions.
Holders
57
Holders Change
+9
Holders Change %
+18.75%
% of All Funds
1.27%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.16%
New
17
Increased
17
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
Adage Capital Partners
Boston,
Massachusetts
|
$11.9M |
2 |
2
Invesco
Atlanta,
Georgia
|
$5.46M |
3 |
GTC
3
Ghost Tree Capital
New York
|
$8.39M |
4 |
SB
4
Samsara BioCapital
Palo Alto,
California
|
$2.96M |
5 |
FI
5
Fosun International
Hong Kong,
China
|
$2.44M |